Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 15 (2017): Issue 8 (Aug 2017)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
NCCN News
Pages: xxvii–xxix
Oncology Research Program
Pages: xxxv–xxxvi
When It's Really Good, We Know It!
By:
Margaret Tempero
Pages: 973
To the Editor: How Do We Solve This Confusion?
Pages: 975–976
Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas
By:
Anastasia Drobysheva
,
Laura J. Klesse
,
Daniel C. Bowers
,
Veena Rajaram
,
Dinesh Rakheja
,
Charles F. Timmons
,
Jason Wang
,
Korgun Koral
,
Lynn Gargan
,
Erica Ramos
and
Jason Y. Park
Pages: 978–982
Neoadjuvant Treatment With Trastuzumab and FOLFOX Induces a Complete Pathologic Response in a Metastatic
ERBB2
(HER2)-Amplified Duodenal Cancer
By:
Ahmad Hamad
,
Aatur D. Singhi
,
Nathan Bahary
,
Kevin McGrath
,
Rula Amarin
,
Herbert J. Zeh
and
Amer H. Zureikat
Pages: 983–988
NCCN Guidelines Insights: Palliative Care, Version 2.2017
By:
Maria Dans
,
Thomas Smith
,
Anthony Back
,
Justin N. Baker
,
Jessica R. Bauman
,
Anna C. Beck
,
Susan Block
,
Toby Campbell
,
Amy A. Case
,
Shalini Dalal
,
Howard Edwards
,
Thomas R. Fitch
,
Jennifer Kapo
,
Jean S. Kutner
,
Elizabeth Kvale
,
Charles Miller
,
Sumathi Misra
,
William Mitchell
,
Diane G. Portman
,
David Spiegel
,
Linda Sutton
,
Eytan Szmuilowicz
,
Jennifer Temel
,
Roma Tickoo
,
Susan G. Urba
,
Elizabeth Weinstein
,
Finly Zachariah
,
Mary Anne Bergman
and
Jillian L. Scavone
Pages: 989–997
Race- and Sex-Based Disparities in the Therapy and Outcomes of Squamous Cell Carcinoma of the Anus
By:
Nivedita Arora
,
Arjun Gupta
,
Hong Zhu
,
Alana Christie
,
Jeffrey J. Meyer
,
Saad A. Khan
and
Muhammad S. Beg
Pages: 998–1004
The Evolution of Metastatic Colorectal Cancer Clinical Trials: Application of the ASCO Framework for Assessing Value
By:
Doreen A. Ezeife
,
Sunil Parimi
,
Ellen R. Cusano
,
Matthew K. Smith
,
Tony H. Truong
,
Soundouss Raissouni
,
Yongtao Lin
,
Jose G. Monzon
,
Haocheng Li
,
Vincent C. Tam
and
Patricia A. Tang
Pages: 1005–1013
Costs and Benefits of Extended Endocrine Strategies for Premenopausal Breast Cancer
By:
Janice S. Kwon
,
Gary Pansegrau
,
Melica Nourmoussavi
,
Geoffrey L. Hammond
and
Mark S. Carey
Pages: 1015–1021
Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993–2013
By:
Talia Golan
,
Tal Sella
,
Ofer Margalit
,
Uri Amit
,
Naama Halpern
,
Dan Aderka
,
Einat Shacham-Shmueli
,
Damien Urban
and
Yaacov Richard Lawrence
Pages: 1022–1027
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
By:
Margaret A. Tempero
,
Mokenge P. Malafa
,
Mahmoud Al-Hawary
,
Horacio Asbun
,
Andrew Bain
,
Stephen W. Behrman
,
Al B. Benson III
,
Ellen Binder
,
Dana B. Cardin
,
Charles Cha
,
E. Gabriela Chiorean
,
Vincent Chung
,
Brian Czito
,
Mary Dillhoff
,
Efrat Dotan
,
Cristina R. Ferrone
,
Jeffrey Hardacre
,
William G. Hawkins
,
Joseph Herman
,
Andrew H. Ko
,
Srinadh Komanduri
,
Albert Koong
,
Noelle LoConte
,
Andrew M. Lowy
,
Cassadie Moravek
,
Eric K. Nakakura
,
Eileen M. O'Reilly
,
Jorge Obando
,
Sushanth Reddy
,
Courtney Scaife
,
Sarah Thayer
,
Colin D. Weekes
,
Robert A. Wolff
,
Brian M. Wolpin
,
Jennifer Burns
and
Susan Darlow
Pages: 1028–1061
DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development
By:
Talia Golan
and
Milind Javle
Pages: 1063–1069
Trends in Neoadjuvant Approaches in Pancreatic Cancer
By:
Lingling Du
and
Andrea Wang-Gillam
Pages: 1070–1077
Acting on Rare Driver Alterations: Is Getting a Meaningful Response a Game of Chance or Scientific Rigor?
By:
David R. Braxton
Pages: 1078–1080
Collapse
Expand
Search
Issue
Journal
[3.235.41.241]
3.235.41.241
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
